Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New antibacterial agents under study at Bayer

Nov. 28, 1996

FDA approves Amphotec

Nov. 27, 1996

Children's Hospital of Philadelphia offers antimicrobial peptides for licensing

Nov. 27, 1996

Cationic antimicrobial peptides available for licensing

Nov. 26, 1996

New treatment for S. pneumoniae infection available for licensing

Nov. 26, 1996

Children's Hospital of Philadelphia offers treatment of H. influenzae for licensing

Nov. 26, 1996

Cyclic hexapeptide antifungal agents claimed by Lilly

Nov. 26, 1996

Nyotran progresses towards market introduction

Nov. 25, 1996

New class of antibacterial agents discovered by Zeneca

Nov. 25, 1996

Merck & Co. cephalosporins active against MRSA, MRCNS

Nov. 25, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...